View Document Preview and Link Open Document File Size: 2,12 MB Share Result on Facebook
City Shanghai / Beijing / Yamagata / / Company Sangon Biological Technologies & Service Co. Ltd. / C. Hidalgo-Grass A. E. / Creative Commons / Hindawi Publishing Corporation / / Country Germany / France / Japan / United States / Italy / China / Israel / / Currency pence / / / Facility Capital University of Medical Sciences / Beijing Friendship Hospital / Capital Medical University / National Institute / Deli Xin2 / / IndustryTerm target site / gene bank / / MedicalCondition disease / resistant M. pneumoniae infections / M. pneumoniae pneumonia / Infectious Diseases / infection / community-acquired pneumonia / respiratory infection / Mycoplasma pneumoniae infections / M. pneumoniae infection / respiratory tract infection / serious pneumonia / / MedicalTreatment antibiotics / / Organization Capital Medical University / Beijing / Capital University / Beijing Friendship Hospital / European Union / National Institute for the Control of Pharmaceutical and Biological Products / / Person Deli Xin / Atsushi Harimaya / / Position Academic Editor / MP / TCCCAAGCGTTACTCATGCC Forward / GGTTAGAACTGGTTTTAGCA Forward / / Product penicillin / gentamicin / Macrolide / erythromycin / ciprofloxacin / / PublishedMedium Clinical Microbiology Reviews / Antimicrobial Agents and Chemotherapy / Journal of Clinical Microbiology / The Pediatric Infectious Disease Journal / / Technology DNA Sequencing / Chemotherapy / genotyping / / URL http / SocialTag 
Drug Resistance Mechanisms of Mycoplasma pneumoniae to Macrolide Antibiotics